Obesity

Association of metabolic obesity phenotypes with cognitive decline in the ELSA ‐Brasil study

Diabetes Obes MetabPublished Prospective cohort study

Authors' conclusion

Metabolic dysfunction may be a stronger predictor of subsequent cognitive decline than excess body weight. Dementia prevention strategies may benefit from early identification and management of metabolic dysfunction across all weight categories.

Study context

Population
Adults aged 35–74 years in the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil); mean age 51.1 years, 55% women, 53% Whitebaseline 15,105
Participants
12,795 adults
Exposure
Metabolic obesity phenotypes
Outcome
Cognitive decline (global cognition Z-scores from memory, verbal fluency and TMT-B tests)
Follow-up
Median 8 years
Methodological detailslongitudinal, three waves (2008-2019), mediation analysis
  • Longitudinal
  • Three waves (2008-2019)
  • Mediation analysis

Main finding

As reported in the abstract

Cognitive decline (global cognition Z-score)

Metabolically unhealthy phenotypes, across all body mass index (BMI) categories: faster cognitive decline, β range (all p < 0.001)

−0.037 to −0.053

Metabolically healthy overweight: not associated, β

0.016

95% CI −0.002, 0.034p = 0.081

Metabolically healthy obesity: not associated, β

0.000

95% CI −0.027, 0.026p = 0.981

Observational data: associations, not effects.

Further findings

C-reactive protein (CRP) mediation

No evidence of CRP mediation

BMI and cognitive decline

BMI not associated with cognitive decline, β
−0.001 (95% CI −0.002, 0.000; p = 0.170)

Waist-to-hip ratio (WHR) and cognitive decline

WHR associated with cognitive decline, β
−0.020 (95% CI −0.026, −0.014, p < 0.001)

Original publication

Association of metabolic obesity phenotypes with cognitive decline in the ELSA ‐Brasil study. Diabetes Obes Metab. Published 20 January 2026. doi:10.1111/dom.70466

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.